Clinical Oncology

Papers
(The H4-Index of Clinical Oncology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?102
The Time has Come to Say Goodbye91
Dose Accumulation for Pelvic Stereotactic Ablative Body Radiotherapy Reirradiation. In Regard to Slevin et al.55
OncoFlash: Research Updates in a Flash!45
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re45
The “real” outcome of esophageal cancer in elderly.44
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas42
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)38
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?38
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment35
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital34
OncoFlash – Research Updates in a Flash! (June 2022)32
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year32
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status31
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma29
Instant Oncology: Impower13328
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines28
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity27
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre27
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey26
OncoFlash–Research Updates in a Flash! (December 2022)26
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment25
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project23
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre23
0.05125093460083